1 APC as a major regulator of hESCs self-renewal.

2 In Vivo CRISPR Screen Identifies TgWIP as a Toxoplasma Modulator of Dendritic Cell Migration.

4 Efficacy and Safety of Trifluridine/Tipiracil Treatment in Patients With Metastatic Gastric Cancer Who Had Undergone Gastrectomy: Subgroup Analyses of a Randomized Clinical Trial.

5 Inhaled nebulized glatiramer acetate against Gram-negative bacteria is not associated with adverse pulmonary reactions in healthy, young adult female pigs.

6 Parasite microbiome project: Grand challenges.

7 Vancomycin-resistance gene cluster, vanC, in the gut microbiome of acute leukemia patients undergoing intensive chemotherapy.

8 Alteration of humoral, cellular and cytokine immune response to inactivated influenza vaccine in patients with Sickle Cell Disease.

9 A conditional inducible JAK2V617F transgenic mouse model reveals myeloproliferative disease that is reversible upon switching off transgene expression.

10 Identification of a systemic interferon-γ inducible antimicrobial gene signature in leprosy patients undergoing reversal reaction.

11 Desktop Genetics.

12 Dealing with Patent Fragmentation in Genetics: Can Patent Pools Facilitate the Development of CRISPR Gene-Editing Technology?

13 Enhanced scale and scope of genome engineering and regulation using CRISPR/Cas in Saccharomyces cerevisiae.

14 High-Efficiency, Selection-free Gene Repair in Airway Stem Cells from Cystic Fibrosis Patients Rescues CFTR Function in Differentiated Epithelia.

15 Comparative Genomics of Support Important Traits Concerning the Evolution, Biology and Technological Properties of the Species.

16 Gene manipulation to test links between genome, brain and behavior in developing songbirds: a test case.

17 Xenotransplantation literature update, January/February 2020.

18 A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2.

19 Reemergence of human plague in Yunnan, China in 2016

20 advances in genetic engineering of domestic animals

21 crispr/cas9 mediated disruption of the swedish app allele as a therapeutic approach for early-onset alzheimer’s disease

22 rapid evolution of manifold crispr systems for plant genome editing

23 recent developments of the synthetic biology toolkit for clostridium

24 applications of new breeding technologies for potato improvement

25 crispr-cas systems features and the gene-reservoir role of coagulase-negative staphylococci

26 efficient crispr-mediated post-transcriptional gene silencing in a hyperthermophilic archaeon using multiplexed crrna expression

27 the evolutionary history and diagnostic utility of the crispr-cas system within salmonella enterica ssp. enterica

28 crispr interference (crispri) inhibition of luxs gene expression in e. coli: an approach to inhibit biofilm

29 efficient restoration of the dystrophin gene reading frame and protein structure in dmd myoblasts using the cindel method

30 Insight into Microevolution of Yersinia pestis by Clustered Regularly Interspaced Short Palindromic Repeats

31 Dynamics of CRISPR Loci in Microevolutionary Process of Yersinia pestis Strains

32 Advances and challenges in CAR-T cell therapy for head and neck squamous cell carcinoma.

33 Suitability of Real-Time PCR Methods for New Genomic Technique Detection in the Context of the European Regulations: A Case Study in Arabidopsis.

34 Tissue-specific (ts)CRISPR as an efficient strategy for in vivo screening in Drosophila.

35 Multiplexed detection of proteins, transcriptomes, clonotypes and CRISPR perturbations in single cells.

36 An artificial triazole backbone linkage provides a split-and-click strategy to bioactive chemically modified CRISPR sgRNA

37 Starting the conversation: CRISPR's role in India.

38 Worldwide CRISPR patent landscape shows strong geographical biases.

39 Seamless Genetic Conversion of SMN2 to SMN1 via CRISPR/Cpf1 and Single-Stranded Oligodeoxynucleotides in Spinal Muscular Atrophy Patient-Specific Induced Pluripotent Stem Cells.

40 Reproducibility of CRISPR-Cas9 methods for generation of conditional mouse alleles: a multi-center evaluation.

41 Liposome-based transfection enhances RNAi and CRISPR-mediated mutagenesis in non-model nematode systems

42 A benchmark of computational CRISPR-Cas9 guide design methods.

43 Efficient generation of GHR knockout Bama minipig fibroblast cells using CRISPR/Cas9-mediated gene editing.

44 Case study of xylose conversion to glycolate in Corynebacterium glutamicum: Current limitation and future perspective of the CRISPR-Cas systems

45 CRISPR/Cas9 editing of three CRUCIFERIN C homoeologues alters the seed protein profile in Camelina sativa.

46 CRISPR Disruption of Resulted in the Failure of Emergence and Affected the Wing and Gonad Development in the Silkworm .

47 Ethics assessment in research proposals adopting CRISPR technology

48 Drug Inducible CRISPR/Cas Systems.

49 CRISPR/Cas9 mediated generation of an ovine model for infantile neuronal ceroid lipofuscinosis (CLN1 disease).

50 CRISPR/Cas9-Mediated Treatment Ameliorates the Phenotype of the Epidermolytic Palmoplantar Keratoderma-like Mouse

51 CRISPR/Cas9-mediated simultaneous knockout of Dmrt1 and Dmrt3 does not recapitulate the 46,XY gonadal dysgenesis observed in 9p24.3 deletion patients.

52 Phage Genetic Engineering Using CRISPR–Cas Systems

53 Reproductive CRISPR does not cure disease.

54 Cytosolic delivery of CRISPR/Cas9 ribonucleoproteins for genome editing using chitosan-coated red fluorescent protein.

55 Mitigation of off-target toxicity in CRISPR-Cas9 screens for essential non-coding elements.

56 CRISPR-Cas9-based mutagenesis frequently provokes on-target mRNA misregulation.

57 Use of anti-CRISPR protein AcrIIA4 as a capture ligand for CRISPR/Cas9 detection.

58 A broad-host-range CRISPRi toolkit for silencing gene expression in .

59 CRISPR/Cas-mediated Fubp1 silencing disrupts circadian oscillation of Per1 protein via downregulating Syncrip expression.

60 Effective editing for lysophosphatidic acid acyltransferase 2/5 in allotetraploid rapeseed ( L.) using CRISPR-Cas9 system.

61 Corrigendum to “Pipeline for the generation of gene knockout mice using dual sgRNA CRISPR/Cas9-mediated gene editing” (Analytical Biochemistry (2019) 568 (31–40), (S0003269718309345), (10.1016/j.ab.2018.12.002))

62 CRISPR-Cas9 system: A new-fangled dawn in gene editing.

63 CRISPR/Cas12a mediated genome editing to introduce amino acid substitutions into the mechanosensitive channel MscCG of .

64 Knockout Of Gene By CRISPR/Cas9 Induces Apoptosis And Inhibits Cell Proliferation In Leukemic Cell Lines, HL60 And KG1.

65 Creation of Early Flowering Germplasm of Soybean by CRISPR/Cas9 Technology.

66 Disruption of miRNA Sequences by TALENs and CRISPR/Cas9 Induces Varied Lengths of miRNA Production.

67 CRISPR/Cas9-Mediated Integration of Large Transgene into Pig Locus.

68 A bacteriophage nucleus-like compartment shields DNA from CRISPR nucleases.

69 A bacteriophage nucleus-like compartment shields DNA from CRISPR nucleases

70 The application of the CRISPR-Cas9 system in pv. actinidiae.

71 Magnetically guided non-invasive CRISPR-Cas9/gRNA delivery across blood-brain barrier to eradicate latent HIV-1 infection.

72 An expanded CRISPRi toolbox for tunable control of gene expression in Pseudomonas putida.

73 Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants.

74 Effective CRISPR/Cas9-mediated correction of a Fanconi anemia defect by error-prone end joining or templated repair

75 How We Got to CRISPR: The Dilemma of Being Human.

76 Systematic in vitro profiling of off-target affinity, cleavage and efficiency for CRISPR enzymes.

77 Generation of two LRRK2 homozygous knockout human induced pluripotent stem cell lines using CRISPR/Cas9.

78 RNA-based CRISPR-Mediated Loss-of-Function Mutagenesis in Human Pluripotent Stem Cells.

79 Focusing on human rights: A framework for CRISPR germline genome editing ethics and regulation

80 CRISPR-mediated gene targeting of CK1δ/ε leads to enhanced understanding of their role in endocytosis via phosphoregulation of GAPVD1

81 Correction to: Gene activation in human cells using CRISPR/Cpf1-p300 and CRISPR/Cpf1-SunTag systems

82 Avoidance of Self during CRISPR Immunization.

83 CRISPR/Cas9-Mediated Immunity in Plants Against Pathogens

84 CRISPR-Cas Genome Surgery in Ophthalmology

85 Porcine antiviral activity is increased by CRISPRa-SAM system

86 CRISPR Diagnosis and Therapeutics with Single Base Pair Precision

87 Keeping CRISPR/Cas on-Target

88 Applications of CRISPR/Cas9 in Reproductive Biology

89 CRISPR/Cas9 therapeutics: a cure for cancer and other genetic diseases

90 crispr/cas9 mutagenesis of ul21 in multiple strains of herpes simplex virus reveals differential requirements for pul21 in viral replication

91 efficient mitochondrial genome editing by crispr/cas9

92 non-mendelian dominant maternal effects caused by crispr/cas9 transgenic components in drosophila melanogaster

93 rapid screening for crispr-directed editing of the drosophila genome using white coconversion

94 high-fidelity glucagon-creer mouse line generated by crispr-cas9 assisted gene targeting

95 in vivo editing of the human mutant rhodopsin gene by electroporation of plasmid-based crispr/cas9 in the mouse retina

96 simple meets single: the application of crispr/cas9 in haploid embryonic stem cells

97 generation of a pxr reporter human induced pluripotent stem cell line (pxr-mcherry hipsc) using the crispr/cas9 system

98 benefits of genomic insights and crispr-cas signatures to monitor potential pathogens across drinking water production and distribution systems

99 conserved dna motifs in the type ii-a crispr leader region

100 crispr/cas9-aav mediated knock-in at nrl locus in human embryonic stem cells

101 survival and evolution of crispr-cas system in prokaryotes and its applications

Keyword Connections

Journals

Research Groups

Bibliographies